\"
27 - 29 March, 2017
Sheraton Philadelphia Downtown, Philadelphia, PA

Media Center

Download 2017 Full Agenda

The 6th Annual Anti-Counterfeiting for Pharmaceuticals Summit takes a comprehensive approach to understand the latest regulations for the DSCSA to remain compliant and uphold quality throughbrand protections plans and anti-counterfeiting strategies. Get your copy of the Full Agenda! Or have it sent to your inbox by... Read More

Sponsorship Information

Pharma Anti-Counterfeiting - SPONSORSHIP PROSPECTUS

Please complete the fields below to receive your copy of the 6th Pharma Anti-Counterfeiting & Brand Protection Summit prospectus which includes: Sponsorship Opportunities | Attendee Profile | Sponsorship... Read More

Pharma ACBP - Attendee Snapshot

Please complete the fields below to receive your copy of the 6th Pharma Anti-Counterfeiting & Brand Protection Summit Attendee... Read More

Fast Track Your Attendance

Justify Your Trip Letter

Present your manager with this customizable letter detailing the reasons why you should attend the upcoming event and you'll be sure to receive... Read More

Past Attendee Snapshot

Detailed is an abbreviated list of Anti-Counterfeiting executives who attended the last iteration of the event. Will you be there to see what they... Read More

Anti-counterfeiting for Pharma Registration Form

We are taking early registrations for this fantastic event. Simply download this form and send it back to enquire@iqpc.com to fast track your attendance to this industry-leading... Read More

Infographics

Nipped in the Bud: The Largest Counterfeit Seizures Worldwide

Global counterfeiting is on the rise for a variety of industries, not just pharmaceuticals. This infographic details some of the most high-profile counterfeit goods seizures in recent years, and weighs them against the staggering global scope of the issue - the battles yet to be... Read More

Whitepapers

Anti-Counterfeiting in Pharmaceuticals: How Serialization Challenges Play a Part

One of the major aspects of anti-counterfeiting and brand protection for pharmaceuticals is the implementation of serialization along the supply chain. Ahead of the 6th Pharma Anti-Counterfeiting & Brand Protection summit, we examined the role that serialization challenges play on counterfeiting in pharmaceuticals, as well as sessions from the... Read More

Presentations

TWENTY-FIRST CENTURY THEFT: Brand Protection Strategies in the Digital Age

Christopher Reed, Senior Counsel, Content Protection Policy at Fox Entertainment Group, covers contributing factors to growth of counterfeiting, payment processors as red flags, cooperative approaches to brand protection, and... Read More

AmerisourceBergen: DSCSA Serialization and Pilot Programs

Matt Sample, from AmerisourceBergen, describes his experiences using DSCSA Serialization and Pilot Programs inside his organization in regards to... Read More

How Lexmark Curtailed Counterfeiting and Diversion By Creating A More Intelligent Supply Chain

Is your company contemplating the best strategies to reduce the threat of counterfeiting? Learn about how Lexmark halted these threats with serialization, authentication, and a track and trace strategy through its partnership with Verify... Read More

Cutting-Edge Issues in Brand & Content Protection

Justin Pierce, Partner at Venable, and Cynthia Tregillis, Senior Director, Brand Protection & Trademark Law at Western Digital, go into preventative measures for Border & Customs, the Dark Web, Grey Markets, and more in this... Read More

Interviews with Industry Leaders

Intellectual Property In The Pharmaceutical Industry: Ligia Garta

Legal IQ spoke to Ligia Gata, IP Manager at Bioingenium, to discover the IP challenges faced by the Pharmaceutical industry in 2015. In this interview, Ligia provides insight on the importance of IP for R&D centers and SMEs, the key elements to consider for effectively preserving intellectual property, cutting costs using IP and she responds... Read More

Presentations

Fighting Counterfeit Pharmaceuticals in Colombia

Eugene Hackett, Director, Corporate Security, Bristol-Myers Squibb Company, discusses the improvements in the penal law, the private/public partnership and best practices for combating counterfeits with a focus on Columbia in this past... Read More